These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32031634)

  • 1. Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.
    Murray GL; Bodiyabadu K; Danielewski J; Garland SM; Machalek DA; Fairley CK; Jensen JS; Williamson DA; Tan LY; Mokany E; Durukan D; Bradshaw CS
    J Infect Dis; 2020 Mar; 221(6):1017-1024. PubMed ID: 32031634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains.
    Hamasuna R; Hanzawa H; Moritomo A; Matsumoto M; Aono H; Tomisaki I; Akasaka T; Fujimoto N; Jensen JS
    J Infect Chemother; 2022 Mar; 28(3):377-383. PubMed ID: 34836778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of
    Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Plummer EL; Danielewski J; Vodstrcil LA; Doyle ML; Murray GL
    J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34590993
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of
    Bodiyabadu K; Danielewski J; Garland SM; Machalek DA; Bradshaw CS; Birnie J; Ebeyan S; Lundgren M; Murray G
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33612146
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis.
    Chambers LC; Jensen JS; Morgan JL; Lowens MS; Romano SS; Totten PA; Soge OO; Hughes JP; Golden MR; Manhart LE
    Sex Transm Dis; 2019 Dec; 46(12):805-809. PubMed ID: 31259853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure.
    Vodstrcil LA; Plummer EL; Doyle M; Murray GL; Bodiyabadu K; Jensen JS; Whiley D; Sweeney E; Williamson DA; Chow EPF; Fairley CK; Bradshaw CS
    Clin Infect Dis; 2022 Sep; 75(5):813-823. PubMed ID: 34984438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
    Hamasuna R; Le PT; Kutsuna S; Furubayashi K; Matsumoto M; Ohmagari N; Fujimoto N; Matsumoto T; Jensen JS
    PLoS One; 2018; 13(6):e0198355. PubMed ID: 29883482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan.
    Deguchi T; Ito S; Yasuda M; Kondo H; Yamada Y; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M
    J Infect Chemother; 2017 Sep; 23(9):648-650. PubMed ID: 28462860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
    Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
    BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
    Deguchi T; Kikuchi M; Yasuda M; Ito S
    J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Murray GL; Bodiyabadu K; Vodstrcil LA; Machalek DA; Danielewski J; Plummer EL; Garland SM; Whiley DM; Sweeney EL; Bradshaw CS
    Antimicrob Agents Chemother; 2022 May; 66(5):e0027822. PubMed ID: 35475636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
    Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
    Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.
    Murray GL; Plummer EL; Bodiyabadu K; Vodstrcil LA; Huaman JL; Danielewski JA; Chua TP; Machalek DA; Garland S; Doyle M; Sweeney EL; Whiley DM; Bradshaw CS
    Clin Infect Dis; 2023 Jun; 76(12):2187-2195. PubMed ID: 36722416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium.
    Fernández-Huerta M; Bodiyabadu K; Esperalba J; Bradshaw CS; Serra-Pladevall J; Garland SM; Fernández-Naval C; Jensen JS; Pumarola T; Ebeyan S; Lundgren M; Tan LY; Espasa M; Murray GL
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434719
    [No Abstract]   [Full Text] [Related]  

  • 19. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.
    Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H
    J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.
    Bissessor M; Tabrizi SN; Twin J; Abdo H; Fairley CK; Chen MY; Vodstrcil LA; Jensen JS; Hocking JS; Garland SM; Bradshaw CS
    Clin Infect Dis; 2015 Apr; 60(8):1228-36. PubMed ID: 25537875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.